Adam Koppel Insider Trading $DRNA Dicerna Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Koppel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Adam Koppel in Dicerna Pharmaceuticals Inc
Trading Symbol: DRNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 3,080,237 shares
Current Value: $7,947,011
Latest Transaction: Dec 14 2020
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Adam Koppel in Dicerna Pharmaceuticals Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 14 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Sell | S | 23.40 | 1,000,000 | 23,400,000 | 3,080,237 | 4.1 M to 3.1 M (-24.51 %) |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 21.61 | 15,000 | 324,150 | 15,000 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
Dec 06 2019 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Sell | S | 24.68 | 1,500,000 | 37,020,000 | 4,080,237 | 5.6 M to 4.1 M (-26.88 %) |
Jun 21 2019 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 15.44 | 25,000 | 386,000 | 25,000 | |
Jun 25 2018 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 13.08 | 25,000 | 327,000 | 25,000 | |
Jul 20 2017 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 3.42 | 25,000 | 85,500 | 25,000 | |
Apr 13 2017 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 |
Page: 1